Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
Open Access
- 1 September 2009
- journal article
- review article
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. 4, 367-377
Abstract
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA Memantine is an uncompetitive N-methyl-D-aspartate receptor antagonist with moderate affinity. Its mechanism of action is neuroprotective and potentially therapeutic in several neuropsychiatric diseases. It has been approved by the FDA for the treatment of moderate to severe Alzheimer’s disease (AD) either as a monotherapy or in combination with cholinesterase inhibitors. This review covers key studies of memantine’s safety and efficacy in treating moderate to severe AD. It also covers current research into other dementias including but not exclusively mild AD and vascular dementia. Other studies on the efficacy of memantine for other neuropsychiatric diseases are discussed. Memantine is a safe and effective drug that merits further research on several topics. Clinicians should be aware of new studies and potential uses of memantine because of its safety and efficacy.Keywords: memantine, Alzheimer’s disease, dementiaKeywords
This publication has 98 references indexed in Scilit:
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibitionBiochemical and Biophysical Research Communications, 2009
- Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medicationSubstance Abuse Treatment, Prevention, and Policy, 2008
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2008
- Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenoneBrain Research, 2008
- Tinnitus treatment with memantineOtolaryngology–Head and Neck Surgery, 2008
- Memantine fails to facilitate partial cigarette deprivation in smokers – no role of Memantine in the treatment of nicotine dependency?Journal of Neural Transmission, 2006
- Cognitive Response to Memantine in Moderate to Severe Alzheimer Disease Patients Already Receiving DonepezilAlzheimer Disease & Associated Disorders, 2006
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Evidence that the Loss of the Voltage‐Dependent Mg2+ Block at the N‐Methyl‐D‐Aspartate Receptor Underlies Receptor Activation During Inhibition of Neuronal MetabolismJournal of Neurochemistry, 1992